CTRI/2024/05/068034尚未招募4 期
Clinical and Biomarker evaluation of response to oral immunosuppressants in Moderate to Severe Psoriasis - NI
Surbhi Jain Self0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Clinically diagnosed patients with moderate to severe psoriasis
- •2. Patients aged 18 - 60 years
- •3. PASI score of = 5 or Body surface area involvement of = 10%
- •4. Patients providing informed consent
排除标准
- •1. Patients with uncontrolled or major forms of psoriasis which are life threatening
- •2. Patients on active topical agents
- •3. Patients taking other systemic drugs for psoriasis in last 2 months
- •4. Patient taking other drugs which can interfere with Methotrexate or Apremilast or Cyclosporine
- •5. Patients on biologics within the past 2 weeks
- •6. Patients with liver or renal impairment or anaemia or thrombocytopenia or leukopenia
- •7. Patients with hepatitis B, C, HIV or TB infection
- •8. Patients with a co-existing comorbidity like diabetes mellitus, uncontrolled hypertension and psychiatric illness
- •9. Pregnant and breastfeeding patients
研究者
相似试验
已完成
不适用
Early clinical and biomarker responses after treatment in patients with non-segmental vitiligoVitiligo10035023NL-OMON48618Academisch Medisch Centrum36
招募中
不适用
Effect of oral fosfomycin as a step-down treatment for complicated urinary tract infections induced by ESBL-producing enterobacteriaceaeDiseases of the genitourinary systemKCT0007669Chosun University Hospital300
已完成
2 期
Preclinical and clinical evaluation of the siddha classical drug ATHIMADHURA KULIGAI(oral administration) along with KADUGU ENNAI (external application) in the management of AUTISM SPECTRUM DISORDER.CTRI/2022/02/039889DrBTamil Elakkiya40
进行中（未招募）
1 期
A study to investigate the clinical and immunological effects on field cancerization in patients treated with PD-1 inhibition for advanced or metastatic cutaneous squamous cell carcinomaadvanced or metastatic cutaneous squamous cell carcinomaMedDRA version: 24.1Level: LLTClassification code 10085908Term: Cutaneous squamous cell carcinomaSystem Organ Class: 100000004864EUCTR2021-006372-17-DEMuehlenkreiskliniken AoeR20
进行中（未招募）
1 期
DRelapsing Remitting Multiple SclerosisMedDRA version: 21.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2016-000708-26-ITFONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE50